Glenn Buene

401 total citations
14 papers, 299 citations indexed

About

Glenn Buene is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Glenn Buene has authored 14 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Hematology and 5 papers in Oncology. Recurrent topics in Glenn Buene's work include Multiple Myeloma Research and Treatments (10 papers), Ubiquitin and proteasome pathways (4 papers) and TGF-β signaling in diseases (3 papers). Glenn Buene is often cited by papers focused on Multiple Myeloma Research and Treatments (10 papers), Ubiquitin and proteasome pathways (4 papers) and TGF-β signaling in diseases (3 papers). Glenn Buene collaborates with scholars based in Norway, Sweden and Netherlands. Glenn Buene's co-authors include Anders Waage, Anders Sundan, Kristine Misund, Toril Holien, Siv Helen Moen, Therese Standal, Katarzyna Anna Baranowska, Marita Westhrin, Hanne Hella and Geir Bjørkøy and has published in prestigious journals such as Blood, Cancer Research and Journal of Cell Science.

In The Last Decade

Glenn Buene

14 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Glenn Buene Norway 10 181 113 92 63 35 14 299
Andy Hsu Australia 6 200 1.1× 106 0.9× 113 1.2× 104 1.7× 39 1.1× 10 401
Zhifu Xiang United States 7 176 1.0× 160 1.4× 76 0.8× 79 1.3× 35 1.0× 22 355
Yasuyuki Kaneta Japan 8 174 1.0× 47 0.4× 75 0.8× 39 0.6× 39 1.1× 10 290
Jesús Gil‐Pulido Germany 7 116 0.6× 66 0.6× 117 1.3× 121 1.9× 44 1.3× 9 303
Gabrielle Ernst United States 4 186 1.0× 26 0.2× 72 0.8× 56 0.9× 42 1.2× 5 298
Yuhua Qiu China 10 98 0.5× 48 0.4× 134 1.5× 192 3.0× 43 1.2× 27 341
Ryan M. Carr United States 12 202 1.1× 132 1.2× 96 1.0× 71 1.1× 63 1.8× 34 436
Saskia M. Bergevoet Netherlands 8 224 1.2× 48 0.4× 61 0.7× 59 0.9× 85 2.4× 14 372
Malachia Hoover United States 8 138 0.8× 27 0.2× 78 0.8× 39 0.6× 50 1.4× 10 254
Yanan Min China 11 76 0.4× 186 1.6× 43 0.5× 78 1.2× 30 0.9× 13 305

Countries citing papers authored by Glenn Buene

Since Specialization
Citations

This map shows the geographic impact of Glenn Buene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenn Buene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenn Buene more than expected).

Fields of papers citing papers by Glenn Buene

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glenn Buene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenn Buene. The network helps show where Glenn Buene may publish in the future.

Co-authorship network of co-authors of Glenn Buene

This figure shows the co-authorship network connecting the top 25 collaborators of Glenn Buene. A scholar is included among the top collaborators of Glenn Buene based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glenn Buene. Glenn Buene is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Ma, Qianli, Glenn Buene, Di Wan, et al.. (2021). Revealing the influence of electron beam melted Ti-6Al-4V scaffolds on osteogenesis of human bone marrow-derived mesenchymal stromal cells. Journal of Materials Science Materials in Medicine. 32(9). 97–97. 4 indexed citations
2.
Mjelle, Robin, Marita Westhrin, Muhammad Zahoor, et al.. (2021). Intracellular IL-32 regulates mitochondrial metabolism, proliferation, and differentiation of malignant plasma cells. iScience. 25(1). 103605–103605. 11 indexed citations
3.
Westhrin, Marita, Zejian Zhang, Siv Helen Moen, et al.. (2020). Monoclonal immunoglobulins promote bone loss in multiple myeloma. Blood. 136(23). 2656–2666. 23 indexed citations
4.
Westhrin, Marita, Toril Holien, Muhammad Asif Zahoor, et al.. (2019). Bone Morphogenetic Protein 4 Gene Therapy in Mice Inhibits Myeloma Tumor Growth, But Has a Negative Impact on Bone. JBMR Plus. 4(1). e10247–e10247. 9 indexed citations
5.
Olsen, Oddrun Elise, Hanne Hella, Glenn Buene, et al.. (2018). BMPR2 inhibits activin and BMP signaling via wild-type ALK2. Journal of Cell Science. 131(11). 42 indexed citations
6.
Westhrin, Marita, Siv Helen Moen, Ida Bruun Kristensen, et al.. (2018). Chemerin is elevated in multiple myeloma patients and is expressed by stromal cells and pre-adipocytes. Biomarker Research. 6(1). 21–21. 15 indexed citations
7.
Holien, Toril, Marita Westhrin, Siv Helen Moen, et al.. (2018). BMP4 Gene Therapy Inhibits Myeloma Tumor Growth, but Has a Negative Impact on Bone. Blood. 132(Supplement 1). 1928–1928. 1 indexed citations
8.
Zahoor, Muhammad Asif, Marita Westhrin, Siv Helen Moen, et al.. (2017). Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone loss. Blood Advances. 1(27). 2656–2666. 54 indexed citations
9.
Starheim, Kristian K., Toril Holien, Kristine Misund, et al.. (2016). Intracellular glutathione determines bortezomib cytotoxicity in multiple myeloma cells. Blood Cancer Journal. 6(7). e446–e446. 48 indexed citations
10.
Baranowska, Katarzyna Anna, Kristine Misund, Kristian K. Starheim, et al.. (2016). Hydroxychloroquine potentiates carfilzomib toxicity towards myeloma cells. Oncotarget. 7(43). 70845–70856. 33 indexed citations
11.
Sponaas, Anne‐Marit, Siv Helen Moen, Nina‐Beate Liabakk, et al.. (2015). The proportion of CD16+CD14dim monocytes increases with tumor cell load in bone marrow of patients with multiple myeloma. Immunity Inflammation and Disease. 3(2). 94–102. 26 indexed citations
12.
Holien, Toril, Kristine Misund, Oddrun Elise Olsen, et al.. (2015). MYCamplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy. Oncotarget. 6(26). 22698–22705. 21 indexed citations
13.
Misund, Kristine, Katarzyna Anna Baranowska, Toril Holien, et al.. (2015). Abstract 1768: Chloroquine potentiates carfilzomib but not bortezomib effects on myeloma cells. Cancer Research. 75(15_Supplement). 1768–1768. 1 indexed citations
14.
Tian, Erming, Thea Kristin Våtsveen, Glenn Buene, et al.. (2014). Identification of the source of elevated hepatocyte growth factor levels in multiple myeloma patients. Biomarker Research. 2(1). 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026